Required growth facilitators propel axon regeneration across complete spinal cord injury
- PMID: 30158698
- PMCID: PMC6151128
- DOI: 10.1038/s41586-018-0467-6
Required growth facilitators propel axon regeneration across complete spinal cord injury
Abstract
Transected axons fail to regrow across anatomically complete spinal cord injuries (SCI) in adults. Diverse molecules can partially facilitate or attenuate axon growth during development or after injury1-3, but efficient reversal of this regrowth failure remains elusive4. Here we show that three factors that are essential for axon growth during development but are attenuated or lacking in adults-(i) neuron intrinsic growth capacity2,5-9, (ii) growth-supportive substrate10,11 and (iii) chemoattraction12,13-are all individually required and, in combination, are sufficient to stimulate robust axon regrowth across anatomically complete SCI lesions in adult rodents. We reactivated the growth capacity of mature descending propriospinal neurons with osteopontin, insulin-like growth factor 1 and ciliary-derived neurotrophic factor before SCI14,15; induced growth-supportive substrates with fibroblast growth factor 2 and epidermal growth factor; and chemoattracted propriospinal axons with glial-derived neurotrophic factor16,17 delivered via spatially and temporally controlled release from biomaterial depots18,19, placed sequentially after SCI. We show in both mice and rats that providing these three mechanisms in combination, but not individually, stimulated robust propriospinal axon regrowth through astrocyte scar borders and across lesion cores of non-neural tissue that was over 100-fold greater than controls. Stimulated, supported and chemoattracted propriospinal axons regrew a full spinal segment beyond lesion centres, passed well into spared neural tissue, formed terminal-like contacts exhibiting synaptic markers and conveyed a significant return of electrophysiological conduction capacity across lesions. Thus, overcoming the failure of axon regrowth across anatomically complete SCI lesions after maturity required the combined sequential reinstatement of several developmentally essential mechanisms that facilitate axon growth. These findings identify a mechanism-based biological repair strategy for complete SCI lesions that could be suitable to use with rehabilitation models designed to augment the functional recovery of remodelling circuits.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
Expressing Constitutively Active Rheb in Adult Neurons after a Complete Spinal Cord Injury Enhances Axonal Regeneration beyond a Chondroitinase-Treated Glial Scar.J Neurosci. 2015 Aug 5;35(31):11068-80. doi: 10.1523/JNEUROSCI.0719-15.2015. J Neurosci. 2015. PMID: 26245968 Free PMC article.
-
Regeneration of Propriospinal Axons in Rat Transected Spinal Cord Injury through a Growth-Promoting Pathway Constructed by Schwann Cells Overexpressing GDNF.Cells. 2024 Jul 8;13(13):1160. doi: 10.3390/cells13131160. Cells. 2024. PMID: 38995011 Free PMC article.
-
Astrocyte scar formation aids central nervous system axon regeneration.Nature. 2016 Apr 14;532(7598):195-200. doi: 10.1038/nature17623. Epub 2016 Mar 30. Nature. 2016. PMID: 27027288 Free PMC article.
-
Cell biology of spinal cord injury and repair.J Clin Invest. 2017 Sep 1;127(9):3259-3270. doi: 10.1172/JCI90608. Epub 2017 Jul 24. J Clin Invest. 2017. PMID: 28737515 Free PMC article. Review.
-
Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury.Prog Brain Res. 2002;137:257-73. doi: 10.1016/s0079-6123(02)37020-1. Prog Brain Res. 2002. PMID: 12440372 Review.
Cited by
-
MCT1-mediated endothelial cell lactate shuttle as a target for promoting axon regeneration after spinal cord injury.Theranostics. 2024 Sep 3;14(14):5662-5681. doi: 10.7150/thno.96374. eCollection 2024. Theranostics. 2024. PMID: 39310103 Free PMC article.
-
Astrocyte-Neuron Interactions in Spinal Cord Injury.Adv Neurobiol. 2024;39:213-231. doi: 10.1007/978-3-031-64839-7_9. Adv Neurobiol. 2024. PMID: 39190077 Review.
-
Current treatments after spinal cord injury: Cell engineering, tissue engineering, and combined therapies.Smart Med. 2022 Dec 26;1(1):e20220017. doi: 10.1002/SMMD.20220017. eCollection 2022 Dec. Smart Med. 2022. PMID: 39188731 Free PMC article. Review.
-
Neuronal maturation and axon regeneration: unfixing circuitry to enable repair.Nat Rev Neurosci. 2024 Oct;25(10):649-667. doi: 10.1038/s41583-024-00849-3. Epub 2024 Aug 20. Nat Rev Neurosci. 2024. PMID: 39164450 Review.
-
Single-cell analysis of innate spinal cord regeneration identifies intersecting modes of neuronal repair.Nat Commun. 2024 Aug 15;15(1):6808. doi: 10.1038/s41467-024-50628-y. Nat Commun. 2024. PMID: 39147780 Free PMC article.
References
-
- Tessier-Lavigne M, Goodman CS. The molecular biology of axon guidance. Science. 1996;274:1123–1133. - PubMed
-
- He Z, Jin Y. Intrinsic Control of Axon Regeneration. Neuron. 2016;90:437–451. - PubMed
-
- Sofroniew MV. Disecting spinal cord regeneration. Nature. 2018;557:343–350. - PubMed
-
- Goldberg JL, Klassen MP, Hua Y, Barres BA. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science. 2002;296:1860–1864. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials